Dr. Scott Gottlieb on CDC's new vaccine advisory board: The consequences will be felt for years
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss new members of the CDC's new vaccine advisory board, what to expect in the new vaccine agenda, and more.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
26 minutes ago
- Miami Herald
Jaguar Health Board of Directors Authorizes Company to Include Cryptocurrency as a Treasury Reserve Asset
Strategic decision positions Jaguar to diversify treasury holdings with a long-term digital store of value SAN FRANCISCO, CA / ACCESS Newswire / June 26, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), announced today that its Board of Directors has unanimously authorized the Company to include cryptocurrency as a treasury reserve asset. "Cryptocurrencies continue to gain investor attention and acceptance as a major asset class. We believe selected cryptocurrencies could serve as a strong treasury reserve asset for the Company, diversifying our assets to include a digital store of value that we believe has significant upside potential and may also provide a safeguard against inflation," said Lisa Conte, Jaguar's Founder and CEO. "Jaguar has been approached by several banks and an investor with terms for cryptocurrency transactions. The Company is assessing the potential value to shareholders, and the potential benefits for our core development programs, of making selected cryptocurrencies a treasury reserve asset for the Company." Jaguar's has three core development programs for crofelemer, the Company's novel plant-based prescription medicine: its orphan disease intestinal failure program; its ongoing efforts to make crofelemer available for treatment of cancer therapy-related diarrhea (CTD) in patients with metastatic breast cancer receiving selected targeted therapies; and its ongoing development program to expand access for Canalevia® (crofelemer delayed-release tablets) in dogs from the conditional approval in chemotherapy-induced diarrhea to a potential global approval for acute general diarrhea. Each of these core programs for crofelemer is the subject of business development goals of forging corporate partnerships to bring in non-dilutive funding for the Company. About the Jaguar Health Family of CompaniesJaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo's crofelemer is FDA-approved under the brand name Mytesi® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications. For more information about: Jaguar Health, visit Napo Pharmaceuticals, visit Napo Therapeutics, visit Magdalena Biosciences, visit Canalevia-CA1, visit Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram Forward-Looking StatementsCertain statements in this press release constitute "forward-looking statements." These include statements regarding making selected cryptocurrencies a treasury reserve asset for the Company, Jaguar's belief that selected cryptocurrencies could serve as a strong treasury reserve asset for the Company, Jaguar's belief that there may be significant upside potential in diversifying the Company's assets to include a digital store of value, Jaguar's belief that diversifying the Company's assets to include a digital store of value may provide a safeguard against inflation, the potential value to shareholders of making selected cryptocurrencies a treasury reserve asset for the Company, and the potential benefits for Jaguar's core development programs of making selected cryptocurrencies a treasury reserve asset for the some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. CONTACT:hello@ SOURCE: Jaguar Health, Inc.
Miami Herald
26 minutes ago
- Miami Herald
Deadly virus spread by deer tick kills 1, hospitalizes 2, Wisconsin officials say
A deadly virus, transmitted through tick bites, killed one and hospitalized two others as of June, Wisconsin health officials said. Details about where and how the three individuals contracted Powassan virus in the state were not shared, however the Wisconsin Department of Health Services is recommending health care providers quickly test patients with symptoms of the 'rare' disease. 'POWV is rare, but there has been an increase in the number of cases reported in recent years,' officials said in a June 24 email to health care providers in the state. 'This increase could be from more people becoming infected with POWV, improvements in testing and diagnosis, or some combination of both.' Powassan virus is transmitted through the bite of an infected blacklegged (deer) tick, officials said. The ticks contract the disease when they bite an infected animal, then pass it onto a human as they latch onto them. As of June 17, seven cases of the virus have been reported nationwide, according to the Centers for Disease Control and Prevention. The cases were reported in Wisconsin, New York, New Hampshire and Massachusetts. In 2024, 57 human cases were reported, the most since 2004, according to the CDC. Infection can present asymptomatically, according to the health department, or through a 'non-specific' illness or neurological disease. 'Initial symptoms commonly include fever, headache, vomiting, and generalized weakness. The disease can progress to encephalitis, meningoencephalitis, or aseptic meningitis,' officials said. The virus can later progress into seizures, speech problems or paralysis, among other symptoms. Deer ticks spread other diseases, including Lyme disease and anaplasmosis, health officials said. Experts with AccuWeather recommend long sleeves in areas where there may be ticks, such as woods or tall grass, and to check your body after spending time outdoors.
Newsweek
29 minutes ago
- Newsweek
Sushi Recall as FDA Issues Highest Risk Warning
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A recall of sushi products has been issued the highest risk classification by the U.S. Food and Drug Administration (FDA). Hy-Vee, a supermarket chain headquartered in Iowa, issued a voluntary recall for a range of sushi products on June 5 because of possible listeria contamination. The FDA subsequently issued its Class 1 risk classification on June 25. Newsweek contacted Hy-Vee for comment by email outside regular working hours. Stock image. A recall of numerous Hy-Vee sushi products has been issued a Class 1 risk classification by the FDA. Stock image. A recall of numerous Hy-Vee sushi products has been issued a Class 1 risk classification by the FDA. Frank Duenzl/picture-alliance/dpa/AP Why It Matters A Class I risk classification represents "a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death," according to the FDA. Listeria contamination may lead to a range of symptoms in infected individuals. For those experiencing less severe infections, symptoms include fever, muscle aches, nausea, vomiting and diarrhea, which often last between one and three days, the FDA said. For more severe and potentially life-threatening infections, symptoms may include headaches, stiff neck, confusion, loss of balance and convulsions. Severe infections are particularly dangerous for newborns, adults over age 65 and those with weakened immune systems. What To Know The affected products were sent to Hy-Vee retail locations throughout the Midwest, according to the FDA. The affected products include: Crispy Shrimp Roll 10Pc - 122.5 cases - code: 02-86792-00000 Crunchy Shrimp Roll - 122.5 cases - code: 02-86793-00000 Red Dragon Roll - 122.5 cases - code: 02-86811-00000 Rock N Roll Shrimp 10Ct - 122.5 cases - code: 02-86813-00000 Duo Spicy Calif Shrimp 10Pc - 122.5 cases - code: 02-86832-00000 Duo Spicy Veg Shrimp 10Pc - 122.5 cases - code: 02-86835-00000 Duo Crunchy Calif Shrimp 10Pc - 122.5 cases - code: 02-86840-00000 Duo Crispy Calif Shrimp 10Pc - 122.5 cases - code: 02-86841-00000 Duo Crunchy Veg Shrimp 10Pc - 122.5 cases - code: 02-86846-00000 Duo Crispy Veg Shrimp 10Pc - 122.5 cases - code: 02-86847-00000 Spicy Shrimp Poke Bowl - 122.5 cases - code: 02-86882-00000 What People Are Saying Haley F. Oliver, a professor of food science at Purdue University, previously told Newsweek: "Listeria monocytogenes is a common microorganism that can be found in the natural environment, for example in soil. There are many factors that determine if someone gets listeriosis—a listeria infection. In most instances, an immunocompromised person, so young, old, pregnant or otherwise immunocompromised, must eat contaminated food. The number of bacteria resulting in infection and the amount of time before illness varies considerably. Symptoms vary among people but can include fever, flu-like symptoms, headache, stiff neck, confusion and loss of balance." Mary O'Riordan, a professor of microbiology and immunology at the University of Michigan Medical School, previously told Newsweek: "Listeria has an unusual capacity to grow at refrigerated temperatures. Although the bacterium can contaminate many types of food, cheeses or deli meats that are kept in cold storage for long periods in stores or at home, are a place where Listeria can keep growing. "Early symptoms of listeria infection look similar to other common foodborne infections, including fever, diarrhea and vomiting, so it's often not diagnosed right away. Unfortunately, sometimes listeria can spread into the brain and cause more serious illness, like meningitis. In those cases, if people experience headache, stiff neck or confusion, they should seek urgent medical attention." Cleveland Clinic, on its website: "Listeria is a bacterial infection that's more dangerous during pregnancy. It can cause pregnancy loss, lifelong illness in your child and newborn death. It causes flu-like and digestive symptoms. Avoiding foods like deli meats, soft cheeses and unpasteurized milk can reduce your risk." What Happens Next The recall is listed as ongoing, according to the FDA.
